Tapewire

Nasdaq · USD

DNLI

Denali Therapeutics Inc.

Export transactions ↓
Tapewire entity
1735
SEC CIK
0001714899
Parsed reports
436

Last 12 months

Inside the activity.

0 purchase rows · 7 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202602
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202604
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 03, 2025 Filed Jun 5, 2025 20:34 UTC GrantCommon Stock 6,037 $0.00 $0.00
Disclosure

SEC source: 0001714899-25-000142 · wk-form4_1749155629.xml · nonDerivative · entry 1

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,075

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 6,037 unvested RSUs.

Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:33 UTC GrantStock Option (right to buy) · Derivative 18,111 $0.00 Strike: $13.93 $0.00
Disclosure

SEC source: 0001714899-25-000141 · wk-form4_1749155513.xml · derivative · entry 3

FLATLEY JAY T · CIK 0001189130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,111

Underlying: Common Stock · 18,111 shares

Expires 2035-06-03

F4 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:33 UTC GrantCommon Stock 6,037 $0.00 $0.00
Disclosure

SEC source: 0001714899-25-000141 · wk-form4_1749155513.xml · nonDerivative · entry 1

FLATLEY JAY T · CIK 0001189130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,220

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 6,037 unvested RSUs.

Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:31 UTC GrantStock Option (right to buy) · Derivative 18,111 $0.00 Strike: $13.93 $0.00
Disclosure

SEC source: 0001714899-25-000140 · wk-form4_1749155428.xml · derivative · entry 2

Klein Peter S · CIK 0001478007 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,111

Underlying: Common Stock · 18,111 shares

Expires 2035-06-03

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:31 UTC GrantCommon Stock 6,037 $0.00 $0.00
Disclosure

SEC source: 0001714899-25-000140 · wk-form4_1749155428.xml · nonDerivative · entry 1

Klein Peter S · CIK 0001478007 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,533

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 6,037 unvested RSUs.

Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:29 UTC GrantStock Option (right to buy) · Derivative 18,111 $0.00 Strike: $13.93 $0.00
Disclosure

SEC source: 0001714899-25-000139 · wk-form4_1749155311.xml · derivative · entry 3

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,111

Underlying: Common Stock · 18,111 shares

Expires 2035-06-03

F4 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:29 UTC GrantCommon Stock 6,037 $0.00 $0.00
Disclosure

SEC source: 0001714899-25-000139 · wk-form4_1749155311.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,794

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 6,037 unvested RSUs.

Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:26 UTC GrantStock Option (right to buy) · Derivative 18,111 $0.00 Strike: $13.93 $0.00
Disclosure

SEC source: 0001714899-25-000138 · wk-form4_1749155084.xml · derivative · entry 4

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,111

Underlying: Common Stock · 18,111 shares

Expires 2035-06-03

F5 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:26 UTC GrantCommon Stock 6,037 $0.00 $0.00
Disclosure

SEC source: 0001714899-25-000138 · wk-form4_1749155084.xml · nonDerivative · entry 1

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,257

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 6,037 unvested RSUs.

Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:25 UTC GrantStock Option (right to buy) · Derivative 18,111 $0.00 Strike: $13.93 $0.00
Disclosure

SEC source: 0001714899-25-000137 · wk-form4_1749154899.xml · derivative · entry 2

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,111

Underlying: Common Stock · 18,111 shares

Expires 2035-06-03

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:25 UTC GrantCommon Stock 6,037 $0.00 $0.00
Disclosure

SEC source: 0001714899-25-000137 · wk-form4_1749154899.xml · nonDerivative · entry 1

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,717

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 6,037 unvested RSUs.

Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:23 UTC GrantStock Option (right to buy) · Derivative 18,111 $0.00 Strike: $13.93 $0.00
Disclosure

SEC source: 0001714899-25-000136 · wk-form4_1749154932.xml · derivative · entry 5

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,111

Underlying: Common Stock · 18,111 shares

Expires 2035-06-03

F6 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:23 UTC GrantCommon Stock 6,037 $0.00 $0.00
Disclosure

SEC source: 0001714899-25-000136 · wk-form4_1749154932.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,886,576

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 6,037 unvested RSUs.

Read SEC document
January 07, 2025 Filed Jan 9, 2025 01:24 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 7,650 $20.81 $159,196.50
Disclosure

SEC source: 0001714899-25-000049 · wk-form4_1736385877.xml · nonDerivative · entry 2

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 253,071

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F3 · balance_after: Includes 177,940 Unvested RSUs.

Read SEC document
January 07, 2025 Filed Jan 9, 2025 01:25 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 2,907 $20.81 $60,494.67
Disclosure

SEC source: 0001714899-25-000050 · wk-form4_1736385937.xml · nonDerivative · entry 2

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 244,308

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F3 · balance_after: Includes 134,030 Unvested RSUs.

Read SEC document
January 07, 2025 Filed Jan 9, 2025 01:23 UTC SaleCommon Stock 3,339 $20.81 $69,484.59
Disclosure

SEC source: 0001714899-25-000048 · wk-form4_1736385830.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,757

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · balance_after: Includes 5,967 Unvested RSUs.

Read SEC document
January 07, 2025 Filed Jan 9, 2025 01:26 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 2,907 $20.81 $60,494.67
Disclosure

SEC source: 0001714899-25-000051 · wk-form4_1736385991.xml · nonDerivative · entry 2

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,673

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F3 · balance_after: Includes 134,030 Unvested RSUs.

Read SEC document
January 06, 2025 Filed Jan 9, 2025 01:24 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 29,266 $20.22 $591,758.52
Disclosure

SEC source: 0001714899-25-000049 · wk-form4_1736385877.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 260,721

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.91 to $20.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 177,940 Unvested RSUs.

Read SEC document
January 06, 2025 Filed Jan 9, 2025 01:25 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 12,255 $20.22 $247,796.10
Disclosure

SEC source: 0001714899-25-000050 · wk-form4_1736385937.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 247,215

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.91 to $20.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 134,030 Unvested RSUs.

Read SEC document
January 06, 2025 Filed Jan 9, 2025 01:26 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 12,255 $20.22 $247,796.10
Disclosure

SEC source: 0001714899-25-000051 · wk-form4_1736385991.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,580

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.93 to $20.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 134,030 Unvested RSUs.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 23:59 UTC
Watts Ryan J.Director · President and CEO
GrantStock Option (right to buy) · Derivative 162,540 $0.00 Strike: $21.26 $0.00
Disclosure

SEC source: 0001714899-25-000028 · wk-form4_1736294379.xml · derivative · entry 3

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,540

Underlying: Common Stock · 162,540 shares

Expires 2035-01-02

F4 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2026, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 23:59 UTC
Watts Ryan J.Director · President and CEO
GrantCommon Stock 54,180 $0.00 $0.00
Disclosure

SEC source: 0001714899-25-000028 · wk-form4_1736294379.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 289,987

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2026 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

F2 · balance_after: Includes 192,940 Unvested RSUs.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 23:57 UTC
Schuth Alexander O.COFO and Secretary
GrantStock Option (right to buy) · Derivative 162,540 $0.00 Strike: $21.26 $0.00
Disclosure

SEC source: 0001714899-25-000027 · wk-form4_1736294268.xml · derivative · entry 3

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,540

Underlying: Common Stock · 162,540 shares

Expires 2035-01-02

F4 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2026, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date

Read SEC document
January 03, 2025 Filed Jan 7, 2025 23:57 UTC
Schuth Alexander O.COFO and Secretary
GrantCommon Stock 54,180 $0.00 $0.00
Disclosure

SEC source: 0001714899-25-000027 · wk-form4_1736294268.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 259,470

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2026 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

F2 · balance_after: Includes 141,530 Unvested RSUs.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 23:56 UTC
Ho CaroleChief Medical Officer
GrantStock Option (right to buy) · Derivative 162,540 $0.00 Strike: $21.26 $0.00
Disclosure

SEC source: 0001714899-25-000026 · wk-form4_1736294172.xml · derivative · entry 4

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,540

Underlying: Common Stock · 162,540 shares

Expires 2035-01-02

F5 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2026, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 23:56 UTC
Ho CaroleChief Medical Officer
GrantCommon Stock 54,180 $0.00 $0.00
Disclosure

SEC source: 0001714899-25-000026 · wk-form4_1736294172.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190,835

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2026 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

F2 · balance_after: Includes 141,530 Unvested RSUs.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 21:13 UTC
SATO VICKI LDirector
SaleCommon Stock 3,080 $20.91 $64,402.80
Disclosure

SEC source: 0001714899-25-000001 · wk-form4_1735938823.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,976

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $20.75 to $21.06 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 5,967 unvested RSUs.

Read SEC document
December 31, 2024 Filed Jan 3, 2025 21:14 UTC SaleCommon Stock 30,000 $20.25 $607,500.00
Disclosure

SEC source: 0001714899-25-000002 · wk-form4_1735938858.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,096

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted December 1, 2023.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $20.10 to $20.55 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects an allocation of 30,000 shares from the Steven Edward Krognes Revocable Trust to the Reporting Person.

F4 · balance_after: Includes 13,467 Unvested RSUs.

Read SEC document
December 27, 2024 Filed Dec 31, 2024 21:18 UTC
Schuth Alexander O.COFO and Secretary
Exercise / conversionStock Option (right to buy) · Derivative 6,708 $0.00 Strike: $5.28 $0.00
Disclosure

SEC source: 0001714899-24-000236 · wk-form4_1735679885.xml · derivative · entry 3

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,671

Underlying: Common Stock · 6,708 shares

Expires 2027-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter.

Read SEC document
December 27, 2024 Filed Dec 31, 2024 21:18 UTC
Schuth Alexander O.COFO and Secretary
Exercise / conversionCommon Stock 6,708 $5.28 $35,418.24
Disclosure

SEC source: 0001714899-24-000236 · wk-form4_1735679885.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,290

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 118,810 Unvested RSUs.

Read SEC document
November 25, 2024 Filed Nov 27, 2024 21:44 UTC
Ho CaroleChief Medical Officer
Exercise / conversionStock Option (right to buy) · Derivative 17,845 $0.00 Strike: $0.68 $0.00
Disclosure

SEC source: 0001714899-24-000235 · wk-form4_1732743876.xml · derivative · entry 4

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,155

Underlying: Common Stock · 17,845 shares

Expires 2025-08-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days.

Read SEC document
November 25, 2024 Filed Nov 27, 2024 21:44 UTC
Ho CaroleChief Medical Officer
Exercise / conversionCommon Stock 17,845 $0.68 $12,134.60
Disclosure

SEC source: 0001714899-24-000235 · wk-form4_1732743876.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,655

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 118,810 Unvested RSUs.

Read SEC document
November 22, 2024 Filed Nov 26, 2024 22:19 UTC
Schuth Alexander O.COFO and Secretary
Exercise / conversionStock Option (right to buy) · Derivative 20,516 $0.00 Strike: $0.68 $0.00
Disclosure

SEC source: 0001714899-24-000234 · wk-form4_1732659560.xml · derivative · entry 3

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,562

Underlying: Common Stock · 20,516 shares

Expires 2025-08-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days.

Read SEC document
November 22, 2024 Filed Nov 26, 2024 22:19 UTC
Schuth Alexander O.COFO and Secretary
Exercise / conversionCommon Stock 20,516 $0.68 $13,950.88
Disclosure

SEC source: 0001714899-24-000234 · wk-form4_1732659560.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,582

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.direct: Includes 118,810 Unvested RSUs.

Read SEC document
November 11, 2024 Filed Nov 13, 2024 21:18 UTC Exercise / conversionStock Option (right to buy) · Derivative 47,165 $0.00 Strike: $18.00 $0.00
Disclosure

SEC source: 0001714899-24-000219 · wk-form4_1731532732.xml · derivative · entry 6

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 47,165 shares

Expires 2027-12-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: 25% of the shares subject to the option shall vest on December 7, 2018 and an additional 1/48 of the shares vest monthly thereafter.

Read SEC document
November 11, 2024 Filed Nov 13, 2024 21:18 UTC SaleCommon Stock 32,312 $32.87 $1,062,095.44
Disclosure

SEC source: 0001714899-24-000219 · wk-form4_1731532732.xml · nonDerivative · entry 3

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,220

F2 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted August 12, 2024.

F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $32.54 to $33.28 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F1 · balance_after: Includes 5,967 Unvested RSUs.

Read SEC document
November 11, 2024 Filed Nov 13, 2024 21:18 UTC SaleCommon Stock 27,129 $32.09 $870,569.61
Disclosure

SEC source: 0001714899-24-000219 · wk-form4_1731532732.xml · nonDerivative · entry 2

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,532

F2 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted August 12, 2024.

F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.54 to $32.53 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F1 · balance_after: Includes 5,967 Unvested RSUs.

Read SEC document
November 11, 2024 Filed Nov 13, 2024 21:18 UTC Exercise / conversionCommon Stock 47,165 $18.00 $848,970.00
Disclosure

SEC source: 0001714899-24-000219 · wk-form4_1731532732.xml · nonDerivative · entry 1

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,661

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 5,967 Unvested RSUs.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 21:44 UTC
Schuth Alexander O.COFO and Secretary
Exercise / conversionStock Option (right to buy) · Derivative 15,558 $0.00 Strike: $5.28 $0.00
Disclosure

SEC source: 0001714899-24-000218 · wk-form4_1731447884.xml · derivative · entry 6

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,379

Underlying: Common Stock · 15,558 shares

Expires 2027-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: 25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 21:44 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 300 $31.29 $9,387.00
Disclosure

SEC source: 0001714899-24-000218 · wk-form4_1731447884.xml · nonDerivative · entry 4

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 178,066

F2 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023.

F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.27 to $31.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F1 · balance_after: Includes 118,810 Unvested RSUs.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 21:44 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 2,925 $30.72 $89,856.00
Disclosure

SEC source: 0001714899-24-000218 · wk-form4_1731447884.xml · nonDerivative · entry 3

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 178,366

F2 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023.

F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.21 to $31.17 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F1 · balance_after: Includes 118,810 Unvested RSUs.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 21:44 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 12,333 $29.68 $366,043.44
Disclosure

SEC source: 0001714899-24-000218 · wk-form4_1731447884.xml · nonDerivative · entry 2

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 181,291

F2 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023.

F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.21 to $30.20 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F1 · balance_after: Includes 118,810 Unvested RSUs.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 21:44 UTC
Schuth Alexander O.COFO and Secretary
Exercise / conversionCommon Stock 15,558 $5.28 $82,146.24
Disclosure

SEC source: 0001714899-24-000218 · wk-form4_1731447884.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 193,624

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 118,810 Unvested RSUs.

Read SEC document
November 07, 2024 Filed Nov 12, 2024 21:43 UTC
SATO VICKI LDirector
SaleCommon Stock 1,020 $30.00 $30,600.00
Disclosure

SEC source: 0001714899-24-000217 · wk-form4_1731447801.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 111,056

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024.

F2 · balance_after: Includes 5,967 unvested RSUs.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 21:21 UTC
SATO VICKI LDirector
SaleCommon Stock 3,080 $27.07 $83,375.60
Disclosure

SEC source: 0001714899-24-000208 · wk-form4_1730841680.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,076

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $26.60 to $27.41 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 5,967 unvested RSUs.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 20:30 UTC
Watts Ryan J.Director · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 40,000 $0.00 Strike: $0.68 $0.00
Disclosure

SEC source: 0001714899-24-000206 · wk-form4_1729629050.xml · derivative · entry 4

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,078,091

Underlying: Common Stock · 40,000 shares

Expires 2025-08-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 20:30 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 40,000 $27.69 $1,107,600.00
Disclosure

SEC source: 0001714899-24-000206 · wk-form4_1729629050.xml · nonDerivative · entry 2

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 235,807

F2 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023.

F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $27.49 to $28.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F1 · balance_after: Includes 197,200 Unvested RSUs.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 20:30 UTC
Watts Ryan J.Director · President and CEO
Exercise / conversionCommon Stock 40,000 $0.68 $27,200.00
Disclosure

SEC source: 0001714899-24-000206 · wk-form4_1729629050.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 275,807

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 197,200 Unvested RSUs.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 20:37 UTC SaleCommon Stock 30,000 $29.03 $870,900.00
Disclosure

SEC source: 0001714899-24-000200 · wk-form4_1727901447.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,096

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted December 1, 2023.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.50 to $29.32 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects an allocation of 26,419 shares from the Steven Edward Krognes Revocable Trust to the Reporting Person.

F4 · balance_after: Includes 13,467 Unvested RSUs.

Read SEC document
September 13, 2024 Filed Sep 16, 2024 20:17 UTC
SATO VICKI LDirector
SaleCommon Stock 1,020 $30.00 $30,600.00
Disclosure

SEC source: 0001714899-24-000199 · wk-form4_1726517865.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,156

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024.

F2 · balance_after: Includes 5,967 unvested RSUs.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.